Free newsletter sign up
Sign up to our free newsletter and get the latest
news sent direct to your inbox
Etta Biotech Co., Ltd. Copyright © 2014-2019 All Rights Reserved. 苏ICP备9051029号
Milestone! Mettaforge Therapeutics, a joint venture company of Etta and Mayo, has been officially registered.
PhD student, Shandong University
"22RV1 cell gene editing efficiency meets customer
requirements and homologous repair efficiency is
Department heads, Cyagen Biosciences
"Compared with previous electroporator, the
experimental cost is greatly reduced."
R&D Director, Genepharma
"Lower cost with stable results."
Some Demo Results
Associate professor, SINANO of Chinese Academy of Sciences
X-Porator F1 with a maximum single treatment volume of up to 250ml.
293F,TE: 94.2%, V: 92.7%.
CHO-S,TE: 95.0%, V: 98.5%.
"H1 leads to breakthrough in experiments. The results have been published in the Nano Research this year."